The US pharmaceutical trade association (PhRMA) asked CRA to identify concrete evidence-based proposals on market reforms aimed at creating a more competitive ‘off-patent’ sector in order to generate savings for the Italian National Health Services (SSN).
Working with industry participants, we assessed the potential policy alternatives based on an assessment of the economic and the political realities of the Italian market. This resulted in five potential policy options ranging from tougher enforcement of current generic policy to reforming the incentives for different distribution.
12 CRA consultants named top IP professionals in the 2021 IAM Patent 1000
12 CRA consultants were recognized as leading patent professionals by Intellectual Asset Management (IAM). The IAM Patent 1000 names the best-in-class patent...